Fractyl Health valued at $654.6 million in tepid debut
(Reuters) – Shares of Fractyl Health fell 8.3% on their market debut on Friday, giving the obesity and diabetes drug developer a market capitalization of $654.6 million. After a two-year lull, initial public offerings in the U.S. are expected to rebound in 2024 on firming bets of a soft landing for the world’s largest economy. …
Fractyl Health valued at $654.6 million in tepid debut Read More »







